Boundless Bio Statistics
NASDAQ: BOLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.32-0.06 (-2.52%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Boundless Bio by the numbers
Boundless Bio has a market capitalization of $54.8 million based on 23.61M shares outstanding. With trailing EPS of $-2.46, Boundless Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.1% below its 50-day average and 15.7% above its 200-day average.
Average daily trading volume is 131.34K shares, or about $304,709 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BOLD valuation vs. peer median
| Metric | BOLD | Peer median | Difference |
|---|---|---|---|
| Market cap | $54.78M | $54.20M | +1% |
| Avg. volume | 131.34K | 89.39K | +47% |
Peer median across 8 companies: AZR, XLO, KZIA, CTOR, IBIO, XBIT, TENX, LFVN.
Valuation
- Market cap
- $54.78M
- EPS (TTM)
- $-2.46
- Shares outstanding
- 23.61M
Price and trading
- Previous close
- 2.38
- Open
- 2.35
- Day range
- 2.28 – 2.39
- 52-week range
- 0.961 – 3.16
- 52-week change
- +105.31%
- Beta
- —
- Volume
- 147.87K
- Average volume
- 131.34K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 54.78M
- Forward Pe
- -3.09
- Eps
- -2.46
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.16
- Week52 Low
- 0.96
- Avg Volume
- 131.34K
- Shares Outstanding
- 23.61M
- Ma50
- 2.52
- Ma200
- 2.00
- Pct From52w High
- -26.68%
- Pct From52w Low
- 141.42%